Role of liver fluke granulin in cholangiocarcinogenesis

肝吸虫颗粒蛋白在胆管癌发生中的作用

基本信息

  • 批准号:
    8371253
  • 负责人:
  • 金额:
    $ 39.48万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-21 至 2017-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Infection with the food-borne liver fluke parasites Opisthorchis viverrini and Clonorchis sinensis is a strong risk factor for cholangiocarcinoma (CCA), bile duct cancer, in Thailand, Laos and other locations in East Asia where infection is endemic. As determined by the World Health Organization's International Agency for Research on Cancer, no stronger link exists between human malignancy and a eukaryotic pathogen than that of CCA and liver fluke infection. CCA usually presents late, is a challenge for diagnosis, metastasizes readily and has high mortality - features highlighting the necessity to understand why and how infection with a food- borne parasite leads to a devastating liver cancer. The transformation from chronic infection with O. viverrini to CCA is multi-factorial, but one importan factor appears to be secretion into the bile ducts of parasite proteins with mitogenic properties, driving local proliferation of biliary and hepatic cells and creating a tumorigenic environment. We have identified a homologue of human granulin, a potent growth factor involved in cell proliferation and wound healing, in the excretory/secretory (ES) products of the parasite. O. viverrini granulin, termed Ov-GRN-1, is widely expressed in fluke tissues, including gut and tegument. Furthermore, Ov-GRN-1 locates in situ to the surface of biliary epithelial cells of hamsters experimentally infected with O. viverrini. Recombinant Ov-GRN-1 stimulates proliferation of murine fibroblasts and human CCA cell lines at nanomolar concentrations that can be inhibited by MAPK kinase inhibitors. Antibodies to Ov-GRN-1 inhibited the ability of O. viverrini ES products to induce proliferation of mammalian cell lines in vitro, indicating that Ov-GRN-1 is the major growth factor present in O. viverrini ES. This was the first report of a secreted growth factor from a parasitic worm that induces proliferation of host cells. Significantly, these new findings support a role for this fluke protein in establishment of a tumorigenic environment that may ultimately manifest as CCA. Here we plan to test this hypothesis with a particular emphasis on the role of Ov-GRN-1 in cell cycle progression and wound repair. We propose also to characterize transcriptional and translational responses of cholangiocytes and CCA cell lines to Ov-GRN-1 using proteomic and genomic microarray approaches to understand signaling and other pathways by which liver fluke granulin drives host cell proliferation. In addition, we propose to use gene silencing and vaccination of hamsters to determine whether Ov-GRN-1 is the major, or even sole, growth factor secreted by the parasite. These studies will determine whether Ov-GRN-1 is the Achilles' heel of this parasite that could be exploited as an anti-fluke and indeed anti-cancer vaccine. PUBLIC HEALTH RELEVANCE: Long term infection with liver fluke - a food-borne parasitic worm - leads to cholangiocarcinoma (CCA), a form of liver cancer with a dismal prognosis. We have identified a protein from these parasites that may cause this cancer. Here we propose to investigate the role of this parasite protein (termed granulin) in cancer, which may lead to new treatments and control for fluke infection and CCA.
描述(由申请人提供):感染食源性肝吸虫寄生虫和华支睾吸虫是导致胆管癌(CCA)和胆道癌的重要危险因素,在泰国、老挝和其他感染流行的东亚地区。根据世界卫生组织国际癌症研究机构的研究,在人类恶性肿瘤和真核病原体之间没有比CCA和肝吸虫感染之间更强的联系。CCA通常出现较晚,对诊断是一个挑战,很容易转移,并且死亡率很高--这些特征突出了了解感染食源性寄生虫为什么以及如何导致毁灭性肝癌的必要性。从慢性感染到CCA的转变是多因素的,但一个重要的因素似乎是具有有丝分裂特性的寄生虫蛋白分泌到胆管中,推动胆管和肝细胞的局部增殖,创造一个致癌环境。我们 已经在寄生虫的排泄/分泌产物中发现了人类颗粒蛋白的同系物,这是一种参与细胞增殖和伤口愈合的有效生长因子。Viverrini颗粒蛋白被称为Ov-GRN-1,在吸虫组织中广泛表达,包括肠道和被膜。此外,Ov-GRN-1定位于实验感染金黄地鼠的胆管上皮细胞表面。重组Ov-GRN-1在纳摩尔浓度刺激小鼠成纤维细胞和人CCA细胞系的增殖,该浓度可被MAPK激酶抑制剂抑制。抗Ov-GRN-1抗体在体外能抑制Ov-GRN-1诱导哺乳动物细胞增殖的能力,表明Ov-GRN-1是Ov-GRN-1在Ov-GRN-1中存在的主要生长因子。这是首次报道一种来自寄生虫的分泌生长因子,它可以诱导宿主细胞的增殖。值得注意的是,这些新发现支持这种吸虫蛋白在建立最终可能表现为CCA的致瘤环境中的作用。在这里,我们计划通过特别强调Ov-GRN-1在细胞周期进展和伤口修复中的作用来检验这一假说。我们还建议使用蛋白质组和基因组微阵列方法来表征胆管细胞和CCA细胞系对Ov-GRN-1的转录和翻译反应,以了解肝吸虫颗粒蛋白驱动宿主细胞增殖的信号和其他途径。此外,我们建议使用基因沉默和接种仓鼠来确定Ov-GRN-1是否是寄生虫分泌的主要甚至唯一的生长因子。这些研究将确定Ov-GRN-1是否是这种寄生虫的致命弱点,可以被用作抗吸虫甚至抗癌疫苗。 公共卫生相关性:长期感染肝吸虫--一种食源性寄生虫--会导致胆管癌(CCA),这是一种预后不佳的肝癌。我们已经从这些寄生虫中鉴定出一种可能导致这种癌症的蛋白质。在这里,我们建议研究这种寄生虫蛋白(称为颗粒蛋白)在癌症中的作用,这可能会导致对吸虫感染和CCA的新的治疗和控制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Paul J Brindley其他文献

Programmed knockout mutation of liver fluke granulin , Ov-grn-1 , attenuates 1 virulence and impedes malignant transformation during chronic 2 opisthorchiasis 3 4 5
肝吸虫颗粒蛋白 , Ov-grn-1 的程序性敲除突变,减弱 1 毒力并阻止慢性 2 阿片吸虫病期间的恶性转化 3 4 5
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sujittra Chaiyadet;S. Tangkawattana;M. Smout;Wannaporn;Ittiprasert;V. Mann;Raksawan Deenonpoe;P. Arunsan;Alex;Loukas;Paul J Brindley;T. Laha
  • 通讯作者:
    T. Laha

Paul J Brindley的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Paul J Brindley', 18)}}的其他基金

Antibiotic selection for schistosome transgenesis
血吸虫转基因的抗生素选择
  • 批准号:
    8849840
  • 财政年份:
    2014
  • 资助金额:
    $ 39.48万
  • 项目类别:
Role of liver fluke granulin in cholangiocarcinogenesis
肝吸虫颗粒蛋白在胆管癌发生中的作用
  • 批准号:
    9107394
  • 财政年份:
    2012
  • 资助金额:
    $ 39.48万
  • 项目类别:
Targeting parasite-host communication to combat liver fluke-induced bile duct cancer
针对寄生虫与宿主的通讯来对抗肝吸虫诱发的胆管癌
  • 批准号:
    10453668
  • 财政年份:
    2012
  • 资助金额:
    $ 39.48万
  • 项目类别:
Role of liver fluke granulin in cholangiocarcinogenesis
肝吸虫颗粒蛋白在胆管癌发生中的作用
  • 批准号:
    8549169
  • 财政年份:
    2012
  • 资助金额:
    $ 39.48万
  • 项目类别:
Role of liver fluke granulin in cholangiocarcinogenesis
肝吸虫颗粒蛋白在胆管癌发生中的作用
  • 批准号:
    8707832
  • 财政年份:
    2012
  • 资助金额:
    $ 39.48万
  • 项目类别:
Targeting parasite-host communication to combat liver fluke-induced bile duct cancer
针对寄生虫与宿主的通讯来对抗肝吸虫诱发的胆管癌
  • 批准号:
    10226900
  • 财政年份:
    2012
  • 资助金额:
    $ 39.48万
  • 项目类别:
Role of liver fluke granulin in cholangiocarcinogenesis
肝吸虫颗粒蛋白在胆管癌发生中的作用
  • 批准号:
    8716242
  • 财政年份:
    2012
  • 资助金额:
    $ 39.48万
  • 项目类别:
Transduction of Schistosoma mansoni by pseudotyped retrovirus
假型逆转录病毒转导曼氏血吸虫
  • 批准号:
    7799460
  • 财政年份:
    2009
  • 资助金额:
    $ 39.48万
  • 项目类别:
Transduction of Schistosoma mansoni by pseudotyped retrovirus
假型逆转录病毒转导曼氏血吸虫
  • 批准号:
    7846579
  • 财政年份:
    2009
  • 资助金额:
    $ 39.48万
  • 项目类别:
Transduction of Schistosoma mansoni by pseudotyped retrovirus
假型逆转录病毒转导曼氏血吸虫
  • 批准号:
    7211226
  • 财政年份:
    2007
  • 资助金额:
    $ 39.48万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 39.48万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 39.48万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 39.48万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.48万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 39.48万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 39.48万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 39.48万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 39.48万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 39.48万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 39.48万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了